Cargando…

Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study

Increased non high-density lipoprotein (HDL)/low-density lipoprotein (LDL) cholesterol levels are independent risk factors for cardiovascular (CV) mortality with no documented threshold. A new combination of nutraceuticals (berberine 200 mg, monacolin K 3 mg, chitosan 10 mg and coenzyme Q 10 mg) wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spigoni, Valentina, Aldigeri, Raffaella, Antonini, Monica, Micheli, Maria Maddalena, Fantuzzi, Federica, Fratter, Andrea, Pellizzato, Marzia, Derlindati, Eleonora, Zavaroni, Ivana, Bonadonna, Riccardo C., Dei Cas, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535988/ https://www.ncbi.nlm.nih.gov/pubmed/28704936 http://dx.doi.org/10.3390/ijms18071498

Ejemplares similares

Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation?
por: Derlindati, Eleonora, et al.
Publicado: (2015)

Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes
por: Dei Cas, Alessandra, et al.
Publicado: (2017)

Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects
por: Matone, Alice, et al.
Publicado: (2019)

Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects
por: Matone, Alice, et al.
Publicado: (2017)

Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy
por: Colletti, Alessandro, et al.
Publicado: (2022)

Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics
por: Cinquegrani, Gloria, et al.
Publicado: (2022)

Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells
por: Spigoni, Valentina, et al.
Publicado: (2017)

Effects on Nitric Oxide Production of Urolithins, Gut-Derived Ellagitannin Metabolites, in Human Aortic Endothelial Cells
por: Spigoni, Valentina, et al.
Publicado: (2016)

Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events
por: Spigoni, Valentina, et al.
Publicado: (2020)

Effects of TiO(2) and Co(3)O(4) Nanoparticles on Circulating Angiogenic Cells
por: Spigoni, Valentina, et al.
Publicado: (2015)

SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders
por: Cinquegrani, Gloria, et al.
Publicado: (2022)

Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance
por: Spigoni, Valentina, et al.
Publicado: (2012)

Short-Term Effect of Nutraceutical Fruit Juices on Lipid Metabolism in Patients with Acquired Hypercholesterolemia
por: Ardissino, Diego, et al.
Publicado: (2023)

Lipid-Lowering Nutraceuticals for an Integrative Approach to Dyslipidemia
por: Cheung, Brian, et al.
Publicado: (2023)

Lipomatrix: A Novel Ascorbyl Palmitate-Based Lipid Matrix to Enhancing Enteric Absorption of Serenoa Repens Oil
por: Fratter, Andrea, et al.
Publicado: (2019)

Berberine for Adjunct/Alternative Treatment of Dyslipidemia: A Literature Review
por: Evbayekha, Endurance O, et al.
Publicado: (2023)

Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project
por: Martini, Daniela, et al.
Publicado: (2020)

Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk Reduction
por: Chiesa, Giulia, et al.
Publicado: (2016)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
por: Higashi, Yukihito
Publicado: (2023)

Performance and anthropometric characteristics of Elite Rugby Players
por: Pasin, Federico, et al.
Publicado: (2017)

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia
por: Derosa, Giuseppe, et al.
Publicado: (2020)

Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders
por: Spigoni, Valentina, et al.
Publicado: (2022)

The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China
por: Ge, Pengfei, et al.
Publicado: (2015)

Development of an Oral (Poly)Phenol Challenge Test (Opct) to Identify Aggregate Metabotypes for Dietary (Poly)Phenols and Their Drivers: A Study Protocol
por: Mena, Pedro, et al.
Publicado: (2022)

Lactoferrin from Milk: Nutraceutical and Pharmacological Properties
por: Giansanti, Francesco, et al.
Publicado: (2016)

Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006
por: Martini, Daniela, et al.
Publicado: (2018)

Maintaining Cardiovascular Health in Patients With Mixed Dyslipidemia Optimizing the Management of Hypertriglyceridemia and Non-HDL Cholesterol
por: Ito, Matthew, et al.
Publicado: (2009)

The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review
por: Colletti, Alessandro, et al.
Publicado: (2023)

Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
por: McCubrey, James A., et al.
Publicado: (2017)

Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome
por: DiNicolantonio, James J, et al.
Publicado: (2019)

Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
por: Zhao, Ying, et al.
Publicado: (2021)

Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route
por: Abo El-Enin, Hadel A., et al.
Publicado: (2022)

The Nutraceutical Properties of Ovotransferrin and Its Potential Utilization as a Functional Food
por: Giansanti, Francesco, et al.
Publicado: (2015)

Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims Proposed Under European Community Regulation 1924/2006 in the Framework of Maintenance of Skin Function
por: Martini, Daniela, et al.
Publicado: (2017)

Gut Microbiota, Metabolic Disorders and Breast Cancer: Could Berberine Turn Out to Be a Transversal Nutraceutical Tool? A Narrative Analysis
por: Cazzaniga, Massimiliano, et al.
Publicado: (2022)

Berberine Encapsulated Lecithin–Chitosan Nanoparticles as Innovative Wound Healing Agent in Type II Diabetes
por: Panda, Dibya Sundar, et al.
Publicado: (2021)

Epidemiology and cardiovascular risk factors of aortic stenosis
por: Faggiano, Pompilio, et al.
Publicado: (2006)

Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study
por: Lee, Jennifer S., et al.
Publicado: (2017)

Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals
por: Saheb Sharif-Askari, Fatemeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8fis077834kkjj49n0fhv92clq